Infusional C-myb ASODN in Advanced Hematologic Malignancies
| Status: | Archived |
|---|---|
| Conditions: | Cancer, Blood Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2002 |
| End Date: | June 2011 |
Infusional C-myb Antisense Oligodeoxynucleotide in Advanced Hematological Malignancies
The purpose of this study is to evaluate whether C-myb Antisense (AS) Oligonucleotides
(ODNs)is a possible treatment modality for advanced hematologic malignancies.
We found this trial at
1
site
Click here to add this to my saved trials
